NeurOptimal® Neurofeedback


NeurOptimal® focuses on the central nervous system (CNS) with the goal of calming the CNS so that it works more effectively and efficiently. As the CNS calms, symptoms and issues related to a wide variety of conditions start to gradually fade away.

NeurOptimal monitors your brain waves via EEG technology and gives your brain feedback when it is not operating efficiently. This feedback helps your brain to re-organize and normalize itself. By working with your brain at its own pace and in the order that is right for you, NeurOptimal is free of side effects and has been proven to have long-term benefits.

The training itself is simple, safe, non-invasive and effortless on the part of the user. All of the complexity is contained in the system itself, as it monitors your brainwaves and sends an auditory signal back to the brain prompting it to adjust as needed.

Session by session your central nervous system will learn new and improved ways of operating by making the best use of your brain’s neural resources. The result is a better you: more centered, focused and creative: less reactive or anxious.

Recent studies demonstrate positive benefits from NeurOptimal training for people with insomnia and for “chemo brain” sufferers and show neurofeedback training to be just as effective as Ritalin for treating children with ADHD.

More information on these topics:

The Effect of EEG Biofeedback on Reducing Postcancer Cognitive Impairment
Jean Alvarez, EdD, Fremonta L. Meyer, David L. Granoff and Allan Lundy, Integrative Cancer Therapies; published online 12 April 2013, DOI: 10.1177/1534735413477192

View Abstract & More (HTML)
Effectiveness of EEG Biofeedback as Compared with Methylphenidate in the Treatment of Attention-Deficit / Hyperactivity Disorder: A Clinical Outcome Study
Mohammad Ali Nazari, Laurent Querne, Alain De Broca, Patrick Berquin. Department of Psychology, University of Tabriz, Tabriz, Iran; Department of Paediatric Neurology, Lab. Neurosciences Fonctionnelles & Pathologies, Amiens, France.

View the Study (PDF, 148kb)